Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: @lambertsluncatic: Why is it

Again, you are sigularly accusing me of "aggression" or whatever similar word you intended. However, despite being asked to, you've not substantiated your accusation with anything but additional adjectives that further describe your opinion, but don't substantiate or support it. Please review my posting history and the posting threads associated with them, and point out the ones that are worthy of your misplaced criticism.

I think you'll find that any of my posts that you might characterize as you have, have been limited to those that were in response to another poster's insult, threat, fabrication, or similar volley, and were typically provided with an eye towards helping that poster re-think their initial "aggression". In those initial posts to which I've responded, I've been called slimy, sleazy, pathetic, a liar, and threatened with banishment, etc., among other things, LOL. But you instead have ignored those other posters' "aggresive" actions, and instead pointed the finger at me as the aggressor. Your paradigm could stand reconsideration, and posters to whom I have responded to should be prepared to be called on their actions and / or support their opinions.

Also, PTSC is an investment, not a family member or loved one, lol, so the only "hurt" I feel is on the balance sheet. With what it is, it's a properly allocated portion of my portfolio, so even if the likely occurs, it's not "hurting" me as you seem to infer, nor will it financially in the manner you seem to imply. While not the desired result, it's ultimately ONLY money.

Risk factors and the like aside however, don't excuse the company, it's managers, and directors, nor does it give them the license to act and perform as they have and do. I am a shareholder, so you shouldn't be surprised when you read critical posts that are fact based or opinion, supported by fact, based, nor should the company directors when they receive similar communications.

When you're prepared to support your comments with substiation, I'll be happy to discuss them further with you, but until then, I'll not clutter the board further with this issue. TIA.

Share
New Message
Please login to post a reply